Free Trial

Colgate-Palmolive (CL) Stock Price, News & Analysis

$99.40
+2.91 (+3.02%)
(As of 07/26/2024 ET)
Today's Range
$98.32
$100.60
50-Day Range
$90.93
$99.40
52-Week Range
$67.62
$100.61
Volume
7.14 million shs
Average Volume
3.71 million shs
Market Capitalization
$81.55 billion
P/E Ratio
31.46
Dividend Yield
2.01%
Price Target
$98.58

Colgate-Palmolive MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.78 Rating Score
Upside/​Downside
0.8% Downside
$98.58 Price Target
Short Interest
Healthy
1.09% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.16
Upright™ Environmental Score
News Sentiment
0.45mentions of Colgate-Palmolive in the last 14 days
Based on 45 Articles This Week
Insider Trading
Selling Shares
$1.48 M Sold Last Quarter
Proj. Earnings Growth
9.07%
From $3.53 to $3.85 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.81 out of 5 stars

Consumer Staples Sector

10th out of 136 stocks

Toilet Preparations Industry

2nd out of 14 stocks

CL stock logo

About Colgate-Palmolive Stock (NYSE:CL)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline to a range of traditional and eCommerce retailers, wholesalers, and distributors. It includes pharmaceutical products for dentists and other oral health professionals. Its Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

CL Stock Price History

CL Stock News Headlines

How to build the ultimate dividend portfolio
There’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps? PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE… This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.
Colgate-Palmolive stock rises on Q2 earnings, outlook lift
Colgate-Palmolive's (NYSE:CL) Q2: Beats On Revenue
Colgate-Palmolive (CL) Q2 2024 Earnings Call Transcript
How to build the ultimate dividend portfolio
There’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps? PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE… This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.
CL Stock Earnings: Colgate-Palmolive Beats EPS, Beats Revenue for Q2 2024
Colgate Stock Is Rising After Earnings. Here's Why.
Jefferies Downgrades Colgate-Palmolive (CL)
See More Headlines
Receive CL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Colgate-Palmolive and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/15 Dividend
4/19/2024
Dividend Payable
5/15/2024
Ex-Dividend for 8/15 Dividend
7/19/2024
Today
7/26/2024
Last Earnings
7/26/2024
Next Earnings (Confirmed)
7/26/2024
Dividend Payable
8/15/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Toilet preparations
Sub-Industry
Household Products
CUSIP
19416210
Employees
34,000
Year Founded
1806

Price Target and Rating

Average Stock Price Target
$98.58
High Stock Price Target
$112.00
Low Stock Price Target
$76.00
Potential Upside/Downside
-0.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
18 Analysts

Profitability

Net Income
$2.30 billion
Pretax Margin
19.23%

Debt

Sales & Book Value

Annual Sales
$19.46 billion
Cash Flow
$4.06 per share
Book Value
$1.16 per share

Miscellaneous

Free Float
817,652,000
Market Cap
$81.55 billion
Optionable
Optionable
Beta
0.39

Social Links

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

  • Colgate-Palmolive stock price has been steadily increasing, reaching a 1-year high of $99.08, indicating positive momentum.
  • Analysts have set new price targets for Colgate-Palmolive, with several giving the stock a "buy" rating, suggesting growth potential.
  • Insider selling activities by executives like Sally Massey and John W. Kooyman could indicate confidence in the company's future performance.
  • Colgate-Palmolive operates in two segments: Oral, Personal and Home Care; and Pet Nutrition, diversifying its revenue streams.
  • Recent upgrades in target prices by financial institutions like Stifel Nicolaus and Bank of America reflect positive sentiment towards the company's prospects.

Cons

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

  • Despite positive analyst ratings, there is always a level of risk associated with investing in any stock, including Colgate-Palmolive.
  • High debt-to-equity ratio of 13.21 could pose financial risks for the company in the event of economic downturns or market fluctuations.
  • The current ratio of 1.06 and quick ratio of 0.70 may indicate potential liquidity challenges for Colgate-Palmolive in the short term.
  • While insider selling can sometimes be interpreted positively, it could also raise concerns about the company's future performance or internal dynamics.
  • Market conditions and consumer preferences can change rapidly, impacting the demand for Colgate-Palmolive's products and potentially affecting its stock price.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, July 22, 2024. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com.

CL Stock Analysis - Frequently Asked Questions

How have CL shares performed this year?

Colgate-Palmolive's stock was trading at $79.71 on January 1st, 2024. Since then, CL shares have increased by 24.7% and is now trading at $99.40.
View the best growth stocks for 2024 here
.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) issued its earnings results on Friday, July, 26th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. Colgate-Palmolive's revenue for the quarter was up 4.9% compared to the same quarter last year.

What is Noel Wallace's approval rating as Colgate-Palmolive's CEO?

195 employees have rated Colgate-Palmolive Chief Executive Officer Noel Wallace on Glassdoor.com. Noel Wallace has an approval rating of 95% among the company's employees. This puts Noel Wallace in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Does Colgate-Palmolive have any subsidiaries?

Colgate-Palmolive subsidiaries include Hello Products, EltaMD, PCA SKIN, Laser Brand Toothpaste, Sanex, Tom's of Maine, GABA International, and more.

Who are Colgate-Palmolive's major shareholders?

Colgate-Palmolive's top institutional shareholders include Bank of New York Mellon Corp (0.74%), Sarasin & Partners LLP (0.39%), Swedbank AB (0.35%) and Sumitomo Mitsui Trust Holdings Inc. (0.24%). Insiders that own company stock include Noel R Wallace, Jennifer Daniels, Philip G Shotts, Lorrie M Norrington, John P Bilbrey, C Martin Harris, Sally Massey, Prabha Parameswaran, Panagiotis Tsourapas, Stephen I Sadove, Gregory Malcolm, John W Kooyman, John T Cahill and Patricia Verduin.
View institutional ownership trends
.

How do I buy shares of Colgate-Palmolive?

Shares of CL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Colgate-Palmolive own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Colgate-Palmolive investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), AT&T (T), AbbVie (ABBV), PepsiCo (PEP), Verizon Communications (VZ) and Coca-Cola (KO).

This page (NYSE:CL) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners